Formulation and Drug Delivery

Celltrion Launches Remicade Biosimilar in European Markets

February 25, 2015

Remsima will now be available for patients in 12 additional countries in the European Union.

Biological Safety Cabinets Contain Hazardous Drug Powders

February 25, 2015

Enclosures contain powders and particulates during hazardous drug manipulation.

BMS Furthers its Immuno-Oncology Pipeline with Nearly $1.6 Billion in Investments

February 23, 2015

Bristol-Myers Squibb announced that it reached an agreement to acquire Flexus Biosciences and has entered into a $309-million partnership with Rigel Pharmaceuticals.

Celltrion Announces that Remicade Biosimilar Could Save Up to $380 Million USD

February 23, 2015

Celltrion announced that its Remicade biosimilar, Rensima, could save France, Italy, and the UK up to €336 million in costs to treat Crohn’s disease.

Revlimid Gains FDA Approval for NDMM Patients

February 20, 2015

Celgene announced that its drug, Revlimid, gained FDA approval for the treatment of newly diagnosed multiple myeloma.

Cell Medica Begins Commercial Manufacturing of Cell Therapies

February 19, 2015

The Berlin-Buch facility will begin manufacture of the company’s immune cell therapy.

Single-use Purification Media Improves Efficiency

February 18, 2015

The all-synthetic 3M Emphaze AEX Hybrid Purifier contains both an anion-exchange nonwoven media and a fine-particle, bioburden reduction membrane.

First Hospira Biosimilar mAb Approved in West Europe

February 17, 2015

Hospira’s Inflectra (infliximab), a biosimilar for Remicade, is approved by the European Commission.

New Financial Strategies Needed to Support Biomedical Innovation

February 17, 2015

The ongoing battle over drug reimbursement and pricing has raised questions about whether the pharmaceutical industry can continue to rely on high United States revenues to fund biopharmaceutical R&D.

CDER and Biotech Quality Assessment

February 11, 2015

The Center for Drug Evaluation and Research seeks a more flexible system for assessing biotech product quality.